Skip to main content
. 2019 Apr 4;12(6):801–809. doi: 10.1016/j.tranon.2019.02.016

Supplementary Figure 1.

Supplementary Figure 1

The synergistic anti-leukemic effects of HHT + IPI504 in FLT3-ITD (+) AML samples.

(A -E) The FLT3-ITD (+) primary AML cells were treated with HHT, IPI504 and HHT+IPI504 for 48 h then cell viability was measured by MTT assay. And the CI values were calculated by Calcusyn. The (B), (D) and (E) are relapsed/refractory AML samples.